Jessica Reddy
Affiliations: | 2010-2016 | Biology | Massachusetts Institute of Technology, Cambridge, MA, United States |
Google:
"Jessica Reddy"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nameki RA, Chang H, Yu P, et al. (2023) Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development. Biorxiv : the Preprint Server For Biology |
| Chaves-Moreira D, Mitchell MA, Arruza C, et al. (2022) The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17. Science Signaling. 15: eabm2496 |
| Reddy J, Fonseca MAS, Corona RI, et al. (2021) Predicting master transcription factors from pan-cancer expression data. Science Advances. 7: eabf6123 |
| Nameki R, Chang H, Reddy J, et al. (2020) Transcription factors in epithelial ovarian cancer: Histotype-specific drivers and novel therapeutic targets. Pharmacology & Therapeutics. 107722 |
| Hnisz D, Weintraub AS, Day DS, et al. (2016) Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science (New York, N.Y.) |
| Saint-André V, Federation AJ, Lin CY, et al. (2016) Models of human core transcriptional regulatory circuitries. Genome Research |
| Theunissen TW, Powell BE, Wang H, et al. (2014) Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell. 15: 524-526 |
| Theunissen TW, Powell BE, Wang H, et al. (2014) Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell. 15: 523 |
| Theunissen TW, Powell BE, Wang H, et al. (2014) Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell. 15: 471-87 |
| Kwiatkowski N, Zhang T, Rahl PB, et al. (2014) Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 511: 616-20 |